Long-term follow-up features on rectal MRI during a wait-and-see approach after a clinical complete response in patients with rectal cancer treated with chemoradiotherapy

Diseases of the Colon and Rectum

Volumn 54, Issue 12, 2011, Pages 1521-1528

  Lambregts, Doenja M J ^a   Maas, Monique ^a   Bakers, Frans C H ^a   Cappendijk, Vincent C ^a   Lammering, Guido ^b   Beets, Geerard L ^a   Beets Tan, Regina G H ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRO CLINIC   (Netherlands)

Author keywords

Complete tumor response; Follow up; Locally advanced rectal cancer; Wait and see policy

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER MORPHOLOGY; CANCER RECURRENCE; CHEMORADIOTHERAPY; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; ENDOSCOPIC SURGERY; ENDOSCOPY; FIBROSIS; FOLLOW UP; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; RECTUM BIOPSY; RECTUM CANCER; TREATMENT RESPONSE; WAIT AND SEE POLICY; PATHOLOGY; RECTUM; RECTUM TUMOR; TREATMENT OUTCOME; TUMOR RECURRENCE; WATCHFUL WAITING;

CHEMORADIOTHERAPY; FIBROSIS; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; NEOPLASM RECURRENCE, LOCAL; RECTAL NEOPLASMS; RECTUM; TREATMENT OUTCOME; WATCHFUL WAITING;

EID: 84855173176     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1097/DCR.0b013e318232da89     Document Type: Article

References (20)

1. Glimelius B, Oliveira J. Rectal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2009;20(suppl 4):54-56.
2. Habr-Gama A, Perez RO, Proscurshim I, et al. Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy. J Gastrointest Surg. 2006;10:1319-1329. (Pubitemid 44908999)
3. Lezoche G, Baldarelli M, Guerrieri M, et al. A prospective randomized study with a 5-year minimum follow-up evaluation of transanal endoscopic microsurgery versus laparoscopic total mesorectal excision after neoadjuvant therapy. Surg Endosc. 2008;22:352-358.
4. Borschitz T, Wachtlin D, Mohler M, Schmidberger H, Junginger T. Neoadjuvant chemoradiation and local excision for T2-3 rectal cancer. Ann Surg Oncol. 2008;15:712-720.
5. Maas M, Lambregts DMJ, Van Dam RM, et al. MR-based 'waitand- see' policy in clinical complete responders to chemoradiation in rectal cancer: a promising alternative [abstract]. Ann Oncol 2010; 21(suppl 1):i54.
6. Yu SK, Brown G, Heald RJ, et al. Deferral of rectal cancer surgery following a continued response to preoperative chemoradiotherapy (watch and wait) study: a phase II multicenter study in the United Kingdom [abstract]. J Clin Oncol. 2011;29(suppl 4): abstract 489.
7. Carlomagno C, Pepe S, D'Armiento FP, et al. Predictive factors of complete response to neoadjuvant chemoradiotherapy in patients with rectal cancer. Oncology. 2010;78:369-375.
8. Kim SH, Lee JY, Lee JM, Han JK, Choi BI. Apparent diffusion coefficient for evaluating tumor response to neoadjuvant chemoradiation therapy for locally advanced rectal cancer. Eur Radiol. 2011;21:987-995.
9. Kim DJ, Kim JH, Lim JS, et al. Restaging of rectal cancer with MRimaging after concurrent chemotherapy and radiation therapy. Radiographics. 2010;30:503-516.
10. Barbaro B, Vitale R, Leccisotti L, et al. Restaging locally advanced rectal cancer with MR imaging after chemoradiation therapy. Radiographics. 2010;30:699-716.
11. Habr-Gama A, Perez RO, Wynn G, Marks J, Kessler H, Gama- Rodrigues J. Complete clinical response after neoadjuvant chemoradiation therapy for distal rectal cancer: characterization of clinical and endoscopic findings for standardization. Dis Colon Rectum. 2010;53:1692-1698.
12. Janssen MH, Ollers MC, Riedl RG, et al. Accurate prediction of pathological rectal tumor response after two weeks of preoperative radiochemotherapy using (18)F-fluorodeoxyglucose-positron emission tomography-computed tomography imaging. Int J Radiat Oncol Biol Phys. 2010;77:392-399.
13. van Stiphout RG, Lammering G, Buijsen J, et al. Development and external validation of a predictive model for pathological complete response of rectal cancer patients including sequential PET-CT imaging. Radiother Oncol. 2011;98:126-133.
14. Kim SH, Lee JM, Hong SH, et al. Locally advanced rectal cancer: added value of diffusion-weightedMRimaging in the evaluation of tumor response to neoadjuvant chemo- and radiation therapy. Radiology. 2009;253:116-125.
15. Lambregts DM, Vandecaveye V, Barbaro B, et al. Diffusionweighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study. Ann Surg Oncol. 2011;18:2224-2231.
16. Vliegen RF, Beets GL, Lammering G, et al. Mesorectal fascia invasion after neoadjuvant chemotherapy and radiation therapy for locally advanced rectal cancer: accuracy of MR imaging for prediction. Radiology. 2008;246:454-462.
17. Blomqvist L, Holm T, Göranson H, Jacobsson H, Ohlsén H, Larsson SA.MRimaging,CTandCEAscintigraphy in the diagnosis of local recurrence of rectal carcinoma. Acta Radiol. 1996;37:779-784. (Pubitemid 126710175)
18. Lambregts DM, Cappendijk VC, Maas M, Beets GL, Beets-Tan RG. Value of MRI and diffusion-weighted MRI for the diagnosis of locally recurrent cancer. Eur Radiol. 2011;21:1250-1258.
19. Nishie A, Stolpen AH, Obuchi M, Kuehn DM, Dagit A, Andresen K. Evaluation of locally recurrent pelvic malignancy: performance of T2- and diffusion-weighted MRI with image fusion. J Magn Reson Imaging. 2008;28:705-713.
20. Habr-Gama A, Perez RO, Nadalin W, et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg 2004;240: 711-718. (Pubitemid 39281293)